Mei-Kuang Chen
8PUBLICATIONS
62CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Jan 22, 2026
CDK2 inhibitor BLU-222 synergizes with CDK4/6 inhibitors in drug resistant breast cancers through p21/p27 induction.Linjie Luo, Yan Wang, Tuyen Bui
|Dec 24, 2025
Rb1 deficiency induces synthetic lethality with ATR and PKMYT1 coinhibition in breast cancer cell lines and patient-derived xenografts.Xiao-Ting Jiang, Mei-Kuang Chen, Jiwang Lee
|Aug 26, 2024
Low-Molecular Weight Cyclin E Confers a Vulnerability to PKMYT1 Inhibition in Triple-Negative Breast Cancer.Mi Li, Amriti R Lulla, Yan Wang
|Mar 29, 2024
BRCA1-Mediated Dual Regulation of Ferroptosis Exposes a Vulnerability to GPX4 and PARP Co-Inhibition in BRCA1-Deficient Cancers.Guang Lei, Chao Mao, Amber D Horbath
|Oct 17, 2022
Targeting the ALK-CDK9-Tyr19 kinase cascade sensitizes ovarian and breast tumors to PARP inhibition via destabilization of the P-TEFb complex.Yu-Yi Chu, Mei-Kuang Chen, Yongkun Wei
Pageof 2
Frequent Collaborators
3 joint publications
Kelly K Hunt
3 joint publications
Khandan Keyomarsi
3 joint publications
Yan Wang
2 joint publications
Jing Wang
2 joint publications
Linjie Luo
2 joint publications
Mi Li
2 joint publications
Mien-Chie Hung
1 joint publications
Albino Bacolla
1 joint publications
In-Kwon Kim
1 joint publications
Darin E Jones
